GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new cocktail targets Hard-to-Treat stomach cancers
Disease control Recruiting nowThis study tests whether adding the drug neratinib to a standard chemotherapy combination (FOLFOX) plus two targeted drugs (trastuzumab and pembrolizumab) can shrink tumors in people with HER2-positive stomach, esophageal, or gastroesophageal junction cancer. About 36 adults with…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 16, 2026 22:26 UTC
-
Could surgery boost immunotherapy for stomach cancer?
Disease control Recruiting nowThis study is for people with stomach cancer that has spread to a few other places in the body. It tests whether adding surgery to remove the main tumor and some of the spread, along with other local treatments, to a combination of immunotherapy and chemotherapy helps people live…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for advanced cancers? first human trial of MDX2001 begins
Disease control Recruiting nowThis early-phase trial tests a new drug called MDX2001 in people with advanced solid tumors that have spread. The main goals are to check the drug's safety and see if it can shrink tumors. About 285 adults with various cancers like lung, breast, or colon cancer will take part.
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study tests a new drug called BG-68501 in people with advanced solid tumors (like breast, lung, or ovarian cancer) that have not responded to standard treatments. The goal is to find a safe dose and see if the drug shrinks tumors, either alone or combined with ot…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug shows promise for Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study tests a drug called zanidatamab in people with advanced solid tumors that have high levels of HER2 protein. Participants must have already tried at least one other cancer treatment. The goal is to see if the drug can shrink tumors or stop them from growing. This is not…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Which stomach cancer surgery is easier on patients? new study aims to find out
Symptom relief Recruiting nowThis study compares symptoms in patients who have one of two types of minimally invasive stomach cancer surgery: removing only the upper part of the stomach or the entire stomach. Researchers want to see which surgery leads to better appetite and fewer side effects. The study inv…
Matched conditions: GASTROESOPHAGEAL CANCER
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 22:32 UTC
-
New study tests App-Based nutrition coaching to fight cancer malnutrition
Symptom relief Recruiting nowThis study tests a remote nutrition program (STRONG) for people with gastroesophageal cancer who are starting chemotherapy or radiation. The goal is to see if the program helps reduce malnutrition better than usual care. About 80 adults will take part, using a food-logging app an…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated May 16, 2026 22:31 UTC
-
Thousands of cancer patients help build better detection tests
Knowledge-focused Recruiting nowThis study collects blood and leftover tissue samples from 9,600 adults with different types of cancer, such as breast, lung, and pancreatic cancer. Researchers will use these samples to improve tests that look for tiny bits of cancer DNA in the blood, which may help detect if ca…
Matched conditions: GASTROESOPHAGEAL CANCER
Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC